BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 9273991)

  • 1. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
    Kanzler S; Löhr H; Gerken G; Galle PR; Lohse AW
    Z Gastroenterol; 2001 May; 39(5):339-41, 344-8. PubMed ID: 11413913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis.
    Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B
    Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulse-dose cyclophosphamide therapy for steroid-refractory autoimmune neurological diseases].
    Watanabe T; Shimoji S; Sugiyama Y; Tsukamoto T; Yamamoto T
    Rinsho Shinkeigaku; 1995 Jun; 35(6):611-6. PubMed ID: 8521635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of autoimmune hepatitis.
    Czaja AJ
    Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy of autoimmune hepatitis].
    Heintges T; Mohr L; Niederau C; Strohmeyer G
    Z Gastroenterol; 1995 Aug; 33(8):462-7. PubMed ID: 7483741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of autoimmune hepatitis.
    Nishioka M
    Trop Gastroenterol; 1997; 18(1):3-7. PubMed ID: 9197163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    Banerjee S; Rahhal R; Bishop WP
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of active chronic hepatitis after treatment with cyclophosphamide and prednisolone. Report of four cases.
    Pengelly CD; Jennings RC
    Practitioner; 1975 Feb; 214(1280):233-42. PubMed ID: 1144250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic active hepatitis in a 2 year-old boy: a probable case of autoimmune hepatitis without usually known autoantibodies?].
    Lachaux A; Le Gall C; Bouvier R; Hermier M
    Gastroenterol Clin Biol; 1993; 17(3):233-4. PubMed ID: 8330705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
    Prelipcean CC; Mihai C; Stefănescu C; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
    Seela S; Sheela H; Boyer JL
    Liver Int; 2005 Aug; 25(4):734-9. PubMed ID: 15998423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune chronic active hepatitis].
    Renner EL
    Ther Umsch; 1993 Feb; 50(2):100-9. PubMed ID: 8456413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.